methotrexate has been researched along with Telangiectasis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giger, R; Nisa, L | 1 |
Johansen, J; Overgaard, J; Overgaard, M | 1 |
Andersen, J; Højris, I; Overgaard, J; Overgaard, M | 1 |
Bacchini, P; Bacci, G; Bertoni, F; Capanna, R; Dallari, D; Picci, P; Pignatti, G | 1 |
2 trial(s) available for methotrexate and Telangiectasis
Article | Year |
---|---|
Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymphedema; Mastectomy; Methotrexate; Middle Aged; Morbidity; Radiotherapy, Adjuvant; Range of Motion, Articular; Shoulder; Tamoxifen; Telangiectasis | 2000 |
Telangiectatic osteogenic sarcoma of the extremities. Results in 17 patients treated with neoadjuvant chemotherapy.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Italy; Methotrexate; Necrosis; Osteosarcoma; Osteotomy; Postoperative Care; Preoperative Care; Prostheses and Implants; Survival Rate; Telangiectasis | 1991 |
2 other study(ies) available for methotrexate and Telangiectasis
Article | Year |
---|---|
Dysphagia, oral telangiectasia, and Raynaud syndrome.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; CREST Syndrome; Deglutition Disorders; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Pantoprazole; Raynaud Disease; Telangiectasis | 2012 |
Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Cyclophosphamide; Endpoint Determination; Female; Fibrosis; Fluorouracil; Humans; Logistic Models; Mastectomy, Segmental; Methotrexate; Middle Aged; Pigmentation; Radiotherapy; Randomized Controlled Trials as Topic; Tamoxifen; Telangiectasis | 2007 |